# Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction

> **NCT03167216** · EARLY_PHASE1 · COMPLETED · sponsor: **Northwestern University** · enrollment: 20 (actual)

## Conditions studied

- Chronic Prostatitis With Chronic Pelvic Pain Syndrome

## Interventions

- **DRUG:** Cromolyn Sodium
- **DRUG:** Cetirizine Hydrochloride

## Key facts

- **NCT ID:** NCT03167216
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-01
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-06-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03167216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03167216, "Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03167216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*